Skip to main content
SIBN logo

SI-BONE, Inc.

SIBNNASDAQHealthcareMedical Devices

$19.91Today:- (-)1Y +31.85%

As of Oct 15, 2026 close

Market cap
$885.54M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$11.48$21.89
Volume (live)
-
Avg. volume (3M)
565.01K

SI-BONE (SIBN) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), SI-BONE used $675.00K of cash in operating activities and spent $8.41M on capital expenditures. That left free cash flow of −$9.09M.

SI-BONE Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for SI-BONE, Inc. (SIBN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-18.90-30.91-43.34-61.26-56.57-43.70-38.40-17.45-23.04
Depreciation & Amortization5.774.385.433.452.091.130.770.721.01
Deferred Income Tax0.000.000.000.003.562.210.000.661.95
Stock Based Compensation25.5225.8724.0623.0616.8711.930.002.311.44
Change in Working Capital-14.33-10.12-4.83-7.64-5.76-2.53-0.48-1.020.38
Change in Accounts Receivable-3.03-5.84-2.12-6.48-0.57-2.19-3.24-1.02-1.31
Change in Inventory-8.68-8.05-4.72-5.71-5.78-0.27-2.11-0.76-0.98
Change in Accounts Payable-1.761.86-1.122.53-0.530.840.380.250.81
Change in Other Working Capital0.691.910.972.02-0.59-0.904.480.511.86
Other Operating Activities0.69-1.640.970.733.840.296.480.260.72
Net Cash from Operating Activities-0.68-12.43-18.71-41.66-39.53-30.66-31.63-14.52-17.53
Investing Activities
Capital Expenditures-8.41-10.50-7.80-9.51-6.39-2.56-2.45-0.94-0.48
Acquisitions0.000.000.000.00-57.9760.360.000.000.00
Purchases of Investments-192.53-205.38-189.50-119.51-102.02-179.17-143.86-96.880.00
Sales/Maturities of Investments205.10228.50137.50126.20159.99118.81159.800.000.00
Other Investing Activities0.000.000.000.0057.97-60.360.00-96.880.00
Net Cash from Investing Activities4.1612.62-59.80-2.8251.58-62.9213.49-97.83-0.48
Financing Activities
Debt Repayment0.000.00-35.280.00-41.00-0.750.000.0013.69
Common Stock Issued3.380.0083.672.204.91134.623.53115.510.38
Common Stock Repurchased0.000.000.000.000.000.000.00-0.070.00
Other Financing Activities0.001.96-0.040.00-0.622.54-0.04-0.36-0.83
Net Cash from Financing Activities3.381.9690.932.20-1.71136.403.49115.1512.86
Summary
Effect of Forex Changes on Cash0.43-0.480.13-0.43-0.500.32-0.04-0.09-0.35
Net Change in Cash7.291.6812.55-42.709.8443.15-14.692.71-5.49
Cash at Beginning of Period34.9533.2720.7263.4253.5810.4425.1222.4127.90
Cash at End of Period42.2434.9533.2720.7263.4253.5810.4425.1222.41
Free Cash Flow-9.09-22.92-26.51-51.16-45.92-33.22-34.07-15.46-18.01
Supplemental Disclosures
Interest Paid-3.353.262.623.23----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About SI-BONE Cash Flow

What is SI-BONE's free cash flow?

SI-BONE had negative free cash flow of $9.09M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$675.00K minus $8.41M of capital expenditures.

How much does SI-BONE spend on capital expenditures?

SI-BONE spent $8.41M on capital expenditures in fiscal 2025, compared with $10.50M a year earlier.

Does SI-BONE pay dividends or buy back shares?

SI-BONE's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition